Assessing Rubella Immunity: Seroprevalence among Pregnant Women in Brazzaville, Congo
Background: Rubella constitutes an important public health problem due to the potential teratogenic effect of the virus when infection occurs early in pregnancy. The objective of this study was to determine the rubella serological profile of pregnant women. Methodology: We conducted a prospective cross-sectional study from January 1 to March 31, 2022, a period of 3 months. Venous blood samples from 98 pregnant women who came for biological investigations to the laboratory of the Blanche Gomez Specialized Mother-Child Hospital (Brazzaville, Congo) were analyzed. The determination of immunoglobulins G and M was carried out on the Architect i1000SR analyzer (ABBOTT) using the chemiluminescence immunological technique
